Tony Merriman New Zealand autoimmunity researcher
Merriman, Tony
VIAF ID: 37146332842818730658 (Personal)
Permalink: http://viaf.org/viaf/37146332842818730658
Preferred Forms
- 100 1 _ ‡a Merriman, Tony
- 100 1 _ ‡a Merriman, Tony
-
-
- 100 0 _ ‡a Tony Merriman ‡c New Zealand autoimmunity researcher
4xx's: Alternate Name Forms (5)
5xx's: Related Names (1)
Works
Title | Sources |
---|---|
Gout | |
Mendelian randomization analysis associates increased serum urate, due to genetic variation in uric acid transporters, with improved renal function | |
Mendelian randomization analysis to examine for a causal effect of urate on bone mineral density | |
Meta-analysis confirms a role for deletion in FCGR3B in autoimmune phenotypes | |
Meta-Analysis of Genome-Wide Association Studies for Abdominal Aortic Aneurysm Identifies Four New Disease-Specific Risk Loci. | |
Mitochondrial genetic variation and gout in Māori and Pacific people living in Aotearoa New Zealand | |
Modulation of genetic associations with serum urate levels by body-mass-index in humans | |
Mouse models for human hyperuricaemia: a critical review | |
mTOR inhibition by metformin impacts monosodium urate crystal-induced inflammation and cell death in gout: a prelude to a new add-on therapy? | |
Multiple common and rare variants of ABCG2 cause gout | |
Multiplexed nanopore sequencing of HLA-B locus in Māori and Polynesian samples | |
Multiplicative interaction of functional inflammasome genetic variants in determining the risk of gout | |
Mutations in the zinc finger protein gene, ZNF469, contribute to the pathogenesis of keratoconus. | |
New urate-lowering therapies in Aotearoa New Zealand: a response to Dr Lance Gravatt's letter on benzbromarone hepatotoxicity | |
No association between ATP-binding cassette transporter G2 rs2231142 (Q141K) and urate-lowering response to febuxostat | |
No causal effects of serum urate levels on the risk of chronic kidney disease: A Mendelian randomization study | |
No evidence for association of Chr 9p21 variant rs1333049 with gout in New Zealand case-control sample sets | |
A novel diffuse gastric cancer susceptibility variant in E-cadherin (CDH1) intron 2: a case control study in an Italian population | |
Novel germlineCDH1mutations in hereditary diffuse gastric cancer families | |
Nucleotide sequence of pvdD, a pyoverdine biosynthetic gene from Pseudomonas aeruginosa: PvdD has similarity to peptide synthetases | |
The Oxytocin Receptor Gene () Variant rs53576 Is Not Related to Emotional Traits or States in Young Adults | |
Pacific Populations, Metabolic Disease and 'Just-So Stories': A Critique of the 'Thrifty Genotype' Hypothesis in Oceania | |
The Pacific-specific CREBRF rs373863828 allele protects against gestational diabetes mellitus in Māori and Pacific women with obesity | |
Performance of gout definitions for genetic epidemiological studies: analysis of UK Biobank | |
Peroxisome proliferator-activated receptor-γ gene polymorphisms and Crohn’s disease | |
Pharmaceutical interventions for weight-loss maintenance: no effect from cabergoline | |
Plasma oxypurinol as a measure of adherence in clinical trials | |
Pleiotropic effect of the ABCG2 gene in gout: involvement in serum urate levels and progression from hyperuricemia to gout | |
Population Heterogeneity in the Genetic Control of Serum Urate | |
The population pharmacokinetics of allopurinol and oxypurinol in patients with gout | |
Population-specific association between ABCG2 variants and tophaceous disease in people with gout | |
Population-specific factors associated with fractional excretion of uric acid | |
Population-specific influence ofSLC2A9genotype on the acute hyperuricaemic response to a fructose load | |
Population-Specific Resequencing Associates the ATP-Binding Cassette Subfamily C Member 4 Gene With Gout in New Zealand Māori and Pacific Men | |
Positive association of tomato consumption with serum urate: support for tomato consumption as an anecdotal trigger of gout flares | |
PPARGC1B: insight into the expression of the gouty inflammation phenotype: PPARGC1B and gouty inflammation | |
Prevalence of airway and parenchymal abnormalities in newly diagnosed rheumatoid arthritis | |
Prevalence of HLA-B27 in the New Zealand population: effect of age and ethnicity | |
The PTPN22 locus and rheumatoid arthritis: no evidence for an effect on risk independent of Arg620Trp | |
The PTPN22 R263Q polymorphism is a risk factor for rheumatoid arthritis in Caucasian case-control samples | |
PTPN22 R620W minor allele is a genetic risk factor for giant cell arteritis | |
Randomised cross-over trial of vildagliptin and pioglitazone as add-on therapy in patients with type 2 diabetes: predicting Which One is Right Here (WORTH) study protocol | |
Rare genetic variants in interleukin-37 link this anti-inflammatory cytokine to the pathogenesis and treatment of gout | |
Re: "Widespread prevalence of a CREBRF variant among Māori and Pacific children is associated with weight and height in early childhood" | |
The relationship of apolipoprotein B and very low density lipoprotein triglyceride with hyperuricemia and gout | |
Relationships Between Allopurinol Dose, Oxypurinol Concentration and Urate-Lowering Response-In Search of a Minimum Effective Oxypurinol Concentration | |
The renal urate transporter SLC17A1 locus: confirmation of association with gout | |
Replication of association of the apolipoprotein A1-C3-A4 gene cluster with the risk of gout | |
Replication of association of the interleukin 23 receptor rs1343151 variant with rheumatoid arthritis in Caucasian sample sets | |
Response to: 'The reference levels of serum urate for clinically evident incident gout' by Chen and Ding | |
Risk factors for cryptorchidism | |
Risk-taking: behind the warrior gene story | |
Role of the urate transporter SLC2A9 gene in susceptibility to gout in New Zealand Māori, Pacific Island, and Caucasian case-control sample sets | |
S1169 KCNN4 Gene Variant Is Associated with Ileal Crohn's Disease | |
S190. SCHIZOTYPY & SUICIDALITY: A MENDELIAN RANDOMISATION ANALYSIS | |
A sequence variant associated with sortilin-1 (SORT1) on 1p13.3 is independently associated with abdominal aortic aneurysm | |
The SLC2A9 nonsynonymous Arg265His variant and gout: evidence for a population-specific effect on severity | |
Smad2:A Candidate Gene for the Murine Autoimmune Diabetes LocusIdd21.1 | |
Smoking behaviour modifiesIL23r-associated disease risk in patients with Crohn's disease | |
SRBreak: A Read-Depth and Split-Read Framework to Identify Breakpoints of Different Events Inside Simple Copy-Number Variable Regions. | |
Subtype-specific gout susceptibility loci and enrichment of selection pressure on ABCG2 and ALDH2 identified by subtype genome-wide meta-analyses of clinically defined gout patients | |
Sugar-sweetened beverage consumption: a risk factor for prevalent gout with SLC2A9 genotype-specific effects on serum urate and risk of gout | |
Systematic genetic analysis of early-onset gout: ABCG2 is the only associated locus | |
Testicular Cancer in New Zealand (TCNZ) study: protocol for a national case-control study | |
Testing the Validity of Taxonic Schizotypy Using Genetic and Environmental Risk Variables | |
TLR2, TLR4 and TLR9 polymorphisms and Crohn's disease in a New Zealand Caucasian cohort | |
The Toll-Like Receptor 4 (TLR4) Variant rs2149356 and Risk of Gout in European and Polynesian Sample Sets | |
Trans-ancestral dissection of urate- and gout-associated major loci SLC2A9 and ABCG2 reveals primate-specific regulatory effects | |
Transmission of haplotypes of microsatellite markers rather than single marker alleles in the mapping of a putative type 1 diabetes susceptibility gene (IDDM6) | |
Trends in the manifestations of 9754 gout patients in a Chinese clinical center: A 10-year observational study | |
Type 1 diabetes, the A1 milk hypothesis and vitamin D deficiency | |
Untangling the complex relationships between incident gout risk, serum urate, and its comorbidities | |
An update on the genetics of hyperuricaemia and gout | |
Urate in fingernail represents the deposition of urate burden in gout patients | |
Urate-lowering therapy alleviates atherosclerosis inflammatory response factors and neointimal lesions in a mouse model of induced carotid atherosclerosis | |
Variable expression quantitative trait loci analysis of breast cancer risk variants | |
Vitamin D receptor gene polymorphism associated with inflammatory bowel disease in New Zealand males | |
What predicts regression from pre-diabetes to normal glucose regulation following a primary care nurse-delivered dietary intervention? A study protocol for a prospective cohort study | |
Workshop report: 4th European crystal network meeting | |
Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010 |